Get started
Work

Supplementary Figure 5 from A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 25K, A comparison of serum concentrations of bevacizumab with and without vismodegib co-treatment
DOI: 10.1158/1078-0432.22445859.v1
Authors: Jordan Berlin, Johanna C. Bendell, Lowell L. Hart, Irfan Firdaus, Ira Gore, Robert C. Hermann, Mary F. Mulcahy, Mark M. Zalupski, Howard M. Mackey, Robert L. Yauch, Richard A. Graham, Gordon L. Bray, Jennifer A. Low
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362429222
Cites:
Cited by:
Related to: 10